About this trial
The aim of this randomized controlled trial is to examine whether single blastocyst transfer in the first cycle after oocyte retrieval (immediate) is non-inferior to single blastocyst transfer in a subsequent cycle (postponed) in stimulated or programmed cycle frozen embryo transfer (FET). The primary outcome is live birth rate.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Eligible for FET in a programmed- or stimulated cycle immediately following a fresh embryo transfer or freeze all cycle
Oligo-anovulatory women (cycle length > 35 days)
Ovulatory women (cycle length 21-35 days)
At least one vitrified day 5 or 6 blastocyst with Gardner score of ≥ 3BB at the day of vitrification
Disqualifiers
Uterine malformation
Presence of hydrosalpinx, submucosal uterine myomas or uterine polyps
Allergies or contraindication to standard fertility medication
Male or female HIV or Hepatitis B or C
Trial design
Parallel
Treatments tested in this trial
Immediate FET in a stimulated or programmed cycle
Procedure/SurgeryPatients will undergo FET in the cycle immediately following oocyte retrieval and a failed fresh embryo transfer or freeze all.
Treatment groups
Trial outcomes
Primary outcomes
Live birth rate
Live birth rate in immediate FET compared to postponed FET in women undergoing FET in a stimulated or programmed cycle.
Secondary outcomes
Live birth rate per blastocyst transfer
Live birth rate overall in both groups
Ongoing pregnancy rate
Ongoing pregnancy rate where pregnancy is assessed by ultrasound in the immediate versus the postponed group
Miscarriage rate
Rate of pregnancy loss in the immediate versus the postponed group
Cancelled cycle rate and reason for cancelled cycles
Cancelled cycle rate in the immediate versus the postponed group
Sponsors and contacts
Click on the lead sponsor to view all of their trials.